MOSCOW (MRC) -- Mitsui Chemicals, Inc. has expanded production facilities to manufacture HI-ZEX MILLION ultra-high molecular weight polyethylene in response to growing demand for automotive and industrial batteries, as per Hydrocarbonprocessing.
This action boosts the company's production capacity for HI-ZEX MILLION by about 15% to 8,500 tons per year.
Mitsui Chemicals developed HI-ZEX MILLION through the application of the company’s proprietary technology in catalysts and processes, giving this ultra-high molecular weight polyethylene an average molecular weight of up to 6 million. Due to the material's excellent chemical resistance, abrasion resistance, impact resistance and self-lubrication, it is used in diverse fields such as lithium-ion battery separators, industrial materials and medical devices.
Furthermore, HI-ZEX MILLION retains a consistent shape and provides excellent solubility. With these properties helping to streamline customers' fabrication processes, the product has been certificated Mitsui Chemical's Blue Value.
Positioning HI-ZEX MILLION as a strategic product in the key business domain of mobility, Mitsui Chemicals will continue to be proactive in further strengthening and expanding this business.
As MRC wrote before, in March 2016, Mitsui & Co., Ltd. and Hankuk Carbon Co., a company listed on the Korea Exchange, entered into a strategic alliance agreement to engage in collaborative business activities relating to the processing of composite materials.
Mitsui Chemicals is a leading manufacturer and supplier of value added specialty chemicals, plastics and materials for the automotive, healthcare, packaging, agricultural, building, and semiconductor and electronics markets. Mitsui Chemicals is a Japanese Chemicals company, a part of the Mitsui conglomerate. The company has a turnover of around 15 billion USD and has business interests in Japan, Europe, China, Southeast Asia and the USA. The company mainly deals in performance materials, petro and basic chemicals and functional polymeric materials.
MRC